PDS Biotechnology (FRA:EU6) Moat Score: 5/10 (As of Jul. 06, 2026)


FRA:EU6 PDS Biotechnology Corp FRA:EU6
32 GF Score
Price €0.75
! 1 Warning Sign
View Full Analysis

What is PDS Biotechnology Moat Score?

PDS Biotechnology FRA:EU6 -2.36% 32 Moat Score is 5 as of Jul. 06, 2026. GuruFocus rates FRA:EU6 with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 1,395 Biotechnology companies, PDS Biotechnology ranks better than 96.7% on this metric.

PDS Biotechnology has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

PDS Biotechnology has Narrow Moat: PDS Biotechnology Corp has a solid narrow moat due to its valuable intellectual property and patents in the biotech sector. The company invests in R&D and innovation, providing some competitive advantage. However, it faces significant competition and regulatory challenges, limiting its moat strength.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes PDS Biotechnology might have Narrow Moat - Solid narrow moat.

PDS Biotechnology  (FRA:EU6) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

PDS Biotechnology Moat Score Related Terms

FRA:EU6 vs LTRN, AURX, VERU: Moat Score Comparison

For the Biotechnology subindustry, PDS Biotechnology's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PDS Biotechnology Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PDS Biotechnology's Moat Score distribution charts can be found below:

* The bar in red indicates where PDS Biotechnology's Moat Score falls into.


FRA:EU6
32GF Score
PDS Biotechnology Corp FRA:EU6
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
PDS Biotechnology (FRA:EU6) has a Moat Score of 5 as of Jul. 06, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, PDS Biotechnology ranks #46 out of 1395 companies in the Biotechnology industry, placing it in the top 3.3%.
Is PDS Biotechnology's Moat Score too high?
PDS Biotechnology's current Moat Score is 5. The Biotechnology industry median Moat Score is 2.00. PDS Biotechnology's value of 5 is 150% above this industry median. Based on the distribution chart, PDS Biotechnology ranks #46 out of 1395 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, PDS Biotechnology has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does PDS Biotechnology's Moat Score compare to LTRN and AURX?
According to the Biotechnology industry distribution chart, PDS Biotechnology ranks #46 out of 1395 companies for Moat Score. This places PDS Biotechnology in the top 3% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. PDS Biotechnology's value of 5 is 150% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,395 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PDS Biotechnology's current Moat Score of 5 is 150% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PDS Biotechnology's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PDS Biotechnology stock overvalued right now?
PDS Biotechnology (FRA:EU6) has a current Moat Score of 5. The current Moat Score is 5 and 150% above the Biotechnology industry median of 2.00. PDS Biotechnology's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For PDS Biotechnology (FRA:EU6), the current Moat Score is 5 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PDS Biotechnology Business Description

Other Exchanges PDSB:USA
Address 303A College Road, East Princeton, NJ, USA, 08540
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
32GF Score

Get the complete analysis for FRA:EU6

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.75
Price